Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

331
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
331
Pneumonia IV: Management01:28

Pneumonia IV: Management

451
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
451
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

442
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
442
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

565
The pathophysiology of pneumonia involves the following steps:
565
Pneumothorax-II01:27

Pneumothorax-II

366
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
366

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combating Vaccine Disinformation: The Professional Responsibilities of Pediatric Nurse Practitioners.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners·2026
Same author

Meningitis Vaccination is at a Crossroads in the United States-What Healthcare Providers Can Do About It.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners·2025
Same author

Parent's perception of respiratory syncytial virus and subsequent wheezing burden: A multi-country cross-sectional survey.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2024
Same author

Vaccine hesitancy: Not a new phenomenon, but a new threat.

Journal of the American Association of Nurse Practitioners·2019
Same author

Social-Emotional Development of Toddlers: Randomized Controlled Trial of an Office-Based Intervention.

Journal of pediatric nursing·2016
Same author

Child and adolescent immunization. Current issues and updates.

Advance for nurse practitioners·2010
Same journal

Expecting the Unexpected.

The Nursing clinics of North America·2026
Same journal

Nursing at the Center of Emergencies.

The Nursing clinics of North America·2026
Same journal

A Scoping Review on Managing Mental Health Emergencies in Elderly Population in WHO Regions.

The Nursing clinics of North America·2026
Same journal

Support Strategies and Policy Recommendations to Manage the Aftermath of an Emergency or Traumatic Situation.

The Nursing clinics of North America·2026
Same journal

Navigating Extreme Weather Events: Experiences of Nursing Leaders in a Rural, Acute Care Hospital in Atlantic Canada.

The Nursing clinics of North America·2026
Same journal

Ensuring Patient-Centered Care During an Emergency in Resource-Constrained Primary Health Care Settings.

The Nursing clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K

Pneumococcal Vaccine.

Mary Koslap-Petraco1

  • 1Stony Brook University School of Nursing, 101 Nicolls Road, Stony Brook, NY 11794-8240, USA.

The Nursing Clinics of North America
|July 27, 2025
PubMed
Summary
This summary is machine-generated.

Pneumococcal conjugate vaccines significantly reduce childhood and adult pneumonia. Updates in vaccine serotypes and administration schedules improve disease prevention, addressing disparities.

Keywords:
PneumococciRacial disparitiesStreptococcus pneumoniaeVaccine administrationVaccine schedulesVaccines

More Related Videos

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.7K
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

45.9K

Related Experiment Videos

Last Updated: Sep 13, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.7K
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

45.9K

Area of Science:

  • Bacteriology
  • Immunology
  • Public Health

Background:

  • Pneumococci are a leading cause of bacterial pneumonia in children under 5 and adults.
  • Community-acquired pneumonia in adults is frequently caused by pneumococci.
  • Pneumococcal conjugate vaccines have dramatically decreased pneumococcal disease incidence.

Purpose of the Study:

  • To review the impact of pneumococcal conjugate vaccines on disease incidence.
  • To discuss the evolution of pneumococcal vaccines, including expanded serotype coverage.
  • To examine changes in vaccine administration schedules based on age and health status.
  • To address the development, implementation, and racial disparities associated with pneumococcal vaccines.

Main Methods:

  • Literature review of pneumococcal disease epidemiology.
  • Analysis of vaccine efficacy data for conjugate pneumococcal vaccines.
  • Examination of public health policy regarding vaccination schedules.
  • Discussion of research on racial disparities in pneumococcal disease and vaccination.

Main Results:

  • Conjugate pneumococcal vaccines have proven highly effective in reducing disease burden.
  • Vaccine formulations have been updated to cover a broader range of pneumococcal serotypes.
  • Vaccination schedules are dynamic, adapting to age and individual risk factors.
  • Racial disparities persist in pneumococcal disease incidence and vaccine uptake.

Conclusions:

  • Pneumococcal conjugate vaccines are critical tools for preventing pneumonia and invasive disease.
  • Ongoing vaccine development and schedule optimization are essential.
  • Addressing racial disparities is crucial for equitable disease prevention.